In Europe, Genetic testing has been growing at an exceptional rate; a large panel of tests are now offered to screen a number of genetic diseases. Treatments are available for a number of rare genetic diseases, and the process is gaining importance in scenarios, such as carrier testing, newborn screening, predictive, and pre-symptomatic testing, among others. Moreover, European countries have undertaken a number of initiatives to increase awareness among people about the benefits of genetic testing. For instance, EuroGentest is a project funded by the European Commission to harmonize the process of genetic testing, from sampling to counseling, across Europe. The ultimate goal is to ensure that all aspects of genetic testing are of high quality, thereby providing accurate and reliable results for the benefit of the patients. In addition, the UK Genetic Testing Network (UKGTN), an advisory organization in UK, promotes equity of access to genetic testing and provides contracting support to the NHS.
Know more details about Genetic Testing Services, download PDF Brochure @ https://bit.ly/2UerepP
Genetic testing comprises a broad range of laboratory tests performed to analyze DNA, RNA, chromosomes, proteins, and certain metabolites using biochemical, cytogenetic, or molecular methods or a combination of these methods.
About 10% to 20% of all cancers are related to gene mutations that are inherited or passed down through the family. Genetic testing is a potential tool to identify the individuals who are at higher risk for developing certain cancers because of family history. Numerous laboratories are offering genetic testing for BRCA and other genes related to hereditary breast, ovarian, and related cancers (HBOC). Moreover, many labs offer multiple types of panels with different combinations of genes. Moreover, approximately 5–10% of cancers diagnosed in the U.S. are associated with hereditary cancer syndromes.
Diagnostics centers are the independent entities that provide all the diagnostic test, screening test and others to the patient. The diagnostics centers are well equipped and offers better results for the test performed for the diseases and health conditions. The diagnostic centers offer all the prenatal diagnostics services such as screening, imaging, blood test, chorionic villus sampling, amniocentesis and others.
Genetic Testing Service market majorly consists of players such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Illumina, Inc., Quest Diagnostics Incorporated, Exact Sciences Corporation, NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Centogene AG, and 23andMe, Inc. Several companies in the market are concentrating on inorganic strategies, such as partnership for enhancing their position in the market. For instance, in January, 2020, Illumina Inc. has announced partnership with Roche. The partnership was carried out to increase patient access to
Source: The Insight Partners